Influence of selected cardiological drugs on oxidative status

Polish Journal of Pharmacology

Volumn 56, Issue 2, 2004, Pages 265-269

  Kopff, Maria ^a   Kowalczyk, Edward ^a   Kopff, Anna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Acetylsalicylic acid; Metoprolol; Molsidomine; Oxidative stress; Simvastatin

Indexed keywords

3 NITROTYROSINE; ACETYLSALICYLIC ACID; CARBONYL DERIVATIVE; CARDIAC AGENT; METOPROLOL; MOLSIDOMINE; NITRIC OXIDE; SIMVASTATIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL GROUP;

ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PLASMA; RABBIT; TISSUE INJURY;

ANIMALS; CARDIOTONIC AGENTS; FEMALE; MALE; OXIDATIVE STRESS; RABBITS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 3142781484     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Arumanayagam M, Chan S, Tong S, Sanderson JE: Antioxidant properties of carvedilol and metoprolol in heart failure: a double-blind randomised controlled trial. J Cardiovasc Pharmacol, 2001, 37, 48-54.
2. Bernstein M, Tyagi SC: β-Blocker improves cardiac function by reducing oxidative stress and metalloproteinase activity after myocardial infarction. 53-rd Annual Fall Conference and Scientific Sessions Council of High Blood Pressure Research of American Heart Association, 13-16 September 1999, Orlando. J Appl Res, 2001, 1, Issue 1 and 2.
3. Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, Da Ras R et al.: Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation, 2002, 106, 1211-1218.
4. Cheng I, Zhao C, Amolius A, Gałazka M, Doneski L: A hypothesis for the in vivo antioxidant action of salicylic acid. Biometals, 1996, 9, 285-290.
5. Cosentino F, Leher TF: Tetrahydrobiopterin and endothelial nitric oxide synthase activity. Cardiovasc Res, 1999, 43, 274-278.
6. Delbasc S, Cristal JP, Decomps B, Mimran A, Jover B: Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress. Hypertension, 2002, 40, 142-147.
7. Delbasc S, Cristal JP, Mimran A, Jover B: Simvastatin attenuates cardiovascular effects and oxidative stress induced by angiotensin II. Arch Mal Coeur Vaiss, 2001, 94, 1199-1202.
8. Delbasc S, Morena M, Djonad F, Ledoucen C, Decomps B, Cristal JP: Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors are able to reduce superoxide anion production by NADPH-oxidase in THP-1-derived monocytes. J Cardiovasc Pharmacol, 2002, 40, 611-617.
9. Ellman G: Tissue sulfhydryl groups. Arch Biochem Biophys, 1959, 82, 70-77.
10. Flesch M, Maach C, Cremers B, Bamar AT, Sudcamp H, Bohm M: Effect of β-blockers on free radical-induced cardiac contractile dysfunction. Circulation, 1999, 100, 346-353.
11. Gavat V, Voroniuc O: Oxidative stress and antioxidants in the diet in pathological processes at the level of the cardiovascular system. Rev Med Chir Soc Med Nat Iasi, 1999, 103, 37-41.
12. Gebicki J: The role of proteins in propagation of radical-induced biological damage. Acta Biochim Pol, 2003, 50, Suppl 1, 10-11.
13. Grune T: Oxidants and antioxidative defense. Hum Exp Toxicol, 2002, 21, 61-62.
14. Gutteridge JMC, Halliwell B: Antioxidants in Nutrition, Health and Diseases. 1st edn, Oxford University Press, New York, 1994.
15. Halliwell B: Introduction - free radicals and human disease - trick or treat? In: Oxygen Radicals and the Disease Process. Ed. Thomasd CE, Kalyanaraman B, 1st edn. Harwood Academic Publishers, Amsterdam, 1997, 1-14.
16. Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine, 2nd edn. Oxford University Press, Oxford, 1989.
17. Imaeda A, Kaneko T, Aoki T, Kondo Y, Nakamura N, Nagase H, Yoshikawa T: Antioxidative effects of fluvastatin and its metabolites against DNA damage in streptozotocin-treated mice. Food Chem Toxicol, 2002, 40, 1415-1422.
18. Janssen YM, van Houten B, Borm PJ, Mossman BT: Cell and tissue responses to oxidative damage. Lab Invest, 1993, 69, 261-274.
19. Joski MS, Ponthier JL, Lancaster JR: Cellular antioxidant and pro-oxidant actions of nitric oxide. Free Radic Biol Med, 1999, 27, 1357-1366.
20. Khan J, Brennan DM, Bradley N, Goa B, Bruckdorfer R, Jacobs M: 3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem J, 1998, 330, 795-801.
21. Kojda G, Harrison DG: Interaction between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Circulation, 2001, 104, 1905-1910.
22. Kukin ML, Kalman J, Charney RH, Levy DK, Buchholz-Varlrley C, Ocampo ON, Eng C: Prospective, randomised comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction and oxidative stress in heart failure. Circulation, 1999, 99, 2645-2651.
23. Levine RL, Garland D, Oliver CN, Amici A, Climent J, Lenz A, Ann B et al.: Determination of carbonyl content of oxidatively modified proteins. Methods Enzymol, 1990, 186, 464-478.
24. Loroy P: Anti- and pro-oxidant aspects of thiols: a physicochemical, biochemical and cellular point of view. Acta Biochim Pol, 2003, 50, Suppl 1, 12-13.
25. Lysko PG, Webb CL, Gu JL, Oklstein EH, Ruffolo RRJr, Yue TL: A comparison of carvedilol and metoprolol antioxidant activities in vitro. J Cardiovasc Pharmacol, 2000, 36, 277-281.
26. Mc Cord JM: Human disease, free radicals and the oxidant/antioxidant balance. Clin Biochem, 1993, 26, 351-357.
27. Nakamura K, Kusano K, Nakamura Y, Kakishita M, Ohta K, Nagase S, Yamamoto M et al.: Carvedilol decreases elevated oxidative stress in human failing myocardium. Circulation, 2002, 105, 2867-2872.
28. Oberle S, Potte T, Abate A, Podhaisky HP, Schrodre H: Asoirin increases ferritin synthesis in endothelial cells. Circ Res, 1998, 82, 1016-1020.
29. Reznick AZ, Packer L: Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol, 1994, 233, 357-363.
30. Rice-Evans CA, Diplock AT, Symons MCR: Techniques in Free Radicals Research. Ed. Burdon RH, Knippenberg PH, Elsevier, Amsterdam, London, New York, Tokyo, 1991.
31. Sies H: Oxidative Stress II: Oxidants and Antioxidants. Academic Press, New York, 1991.
32. Singh N, Dhalla AK, Seneviratene C, Singal PK: Oxidative stress and heart failure. Mol Cell Biochem, 1995, 147, 77-81.
33. Singh RJ, Hogg N, Joseph J, Konorev E, Kalyanaraman B: The peroxynitrite generator, SIN-1, becomes a nitric oxide donor in the presence of electron acceptors. Arch Biochem Biophys, 1999, 361, 331-339.
34. Ter Steege JC, Koster-Kamphuis L, vav Straaten EA, Foget PP, Buurman WA: Nitrotyrosine in plasma of celiac disease patient as detected by a new sandwich ELISA. Free Radic Biol Med, 1998, 25, 953-963
35. Theres H, Wagner KD, Schulz S, Strube S, Leiterer KP, Romberg D, Gunther J et al.: Oxygen radical system in chronic infarcted rat heart: the effect of combined beta blockade and ACE inhibition. J Cardiovasc Pharmacol, 2000, 35, 708-715.
36. Wu R, de Champlain J: Aspirin treatment decreases aortic tissue and cultured aortic smooth muscle cells superoxide production and NAD(P)H oxidase activity in rats. Can Cardiovasc Congress, 2001, Abstracts, 203.
37. Wu R, Lamontague D, de Champlain J: Antioxidative properties of acetylsalicylic acid on vascular tissue from normotensive and spontaneously hypertensive rats. Circulation, 2002, 105, 387-392.